Empty Capsules Market by Type, Raw Material, Functionality, Application, Size, End User

List of Tables

The global empty capsules market is projected to reach USD 4.19 billion by 2030 from an estimated USD 3.19 billion in 2025, at a CAGR of 5.6% from 2025 to 2030.

Scope of the Report
Years Considered for the Study	2024-2030
Base Year	2024
Forecast Period	2025-2030
Units Considered	Value (USD billion)
Segments	Type, Raw Material, Functionality, Size, Therapeutic Application, End User, and Region
Regions covered	North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

The market is fueled by increasing demand for nutraceuticals and personalized supplements, growth in pharmaceutical R&D, and innovations in functional and modified-release capsules. A significant shift toward vegetarian and clean-label options and sustainability-focused regulations is further driving adoption. Future growth is likely to come from localized production in emerging markets and the creation of biodegradable capsules.

"The porcine-derived capsules will continue to be the largest raw material segment in the gelatin capsules market, growing at the highest CAGR."

The gelatin empty capsules market is segmented based on raw material into porcine gelatin, bovine-derived gelatin, bone meal, and other gelatin sources. The non-gelatin capsules market is further categorized into hydroxypropyl methylcellulose (HPMC) and pullulan & starch. The porcine gelatin capsule market is the largest raw material category and is expected to experience the highest growth rate during the forecast period, due to its cost-effectiveness and wide availability. Porcine gelatin is widely used in the pharmaceutical and nutraceutical industries because of its excellent gelling properties, making it suitable for various drug formulations, including solid and controlled-release types.

"Pharmaceutical industry segment reported the highest share of the end user segment in 2024."

Based on end users, the empty capsules market is categorized into pharmaceutical industry, nutraceutical industry, cosmetic industry, and research laboratories. The pharmaceutical industry is the largest end user of empty capsules, widely using them for delivering prescription drugs, over-the-counter (OTC) medications, and therapeutic treatments. These capsules are commonly used for oral administration of solid drugs like antibiotics, pain relievers, antihypertensives, and other medications for managing chronic diseases. Capsules are a preferred dosage form in the pharmaceutical sector because they are easy to swallow, provide accurate dosing, and can encapsulate a broad range of drugs.

North America accounted for the largest global empty capsules market from 2025 to 2030.

In 2024, North America, especially the US and Canada, will be the largest market for empty capsules due to strong demand in pharmaceuticals and nutraceuticals, supported by advanced manufacturing infrastructure and robust regulatory frameworks. Ongoing investments in technology and innovation have led to the development of high-quality capsules for various applications, such as immediate and controlled-release drug delivery. The rising demand for dietary supplements, driven by consumer interest in preventive healthcare and wellness, further fuels market growth. The region also benefits from a favorable regulatory environment, which encourages the adoption of new drug delivery formats, including controlled-release and enteric-coated capsules. Additionally, the Asia Pacific region is expected to see the fastest growth during this period, thanks to expanding pharmaceutical manufacturing capabilities, lower production costs, and supportive government policies. Countries like China, India, and South Korea are becoming key manufacturing hubs due to their large skilled labor pools, low costs, and favorable policies.

The primary interviews conducted for this report can be categorized as follows:

By Respondent: Supply Side-70% and Demand Side-30%
By Designation: Managers-45%, CXO and Directors-30%, and Executives-25%
By Region: North America-40%, Europe-25%, the Asia Pacific-20%, Latin America-10%, and the Middle East & Africa-5%

List of Key Companies Profiled in the Report:

Key players in the Empty capsules market include Lonza (Capsugel) (Switzerland), ACG (India), Suheung (South Korea), Roquette (Qualicaps) (France), Shanxi Guangsheng Medicinal Capsule Co., Ltd (China), Nectar Lifesciences (India), Sunil Healthcare (India), Natural Capsules Limited (India), Baotou Dongbao Bio-Tech Co Ltd. (China), Anhui Huangshan Capsule Co., Ltd. (China), CapsCanada(Lyfe Group) (Canada), Farmacapsulas (Colombia), Healthcaps India (India), Erawat Pharma (India), Comed Chemicals Ltd (India), Fortcaps Healthcare Limited (India), and Shandong Healsee Capsule Ltd. (China).

Research Coverage:

This research report categorizes the empty capsules market, by type (gelatin capsules, non-gelatin capsules), by raw materials (gelatin [porcine-derived gelatin, bovine-derived gelatin, bone meal-derived gelatin, other gelatin sources], non-gelatin [hpmc, pullulan & starch]), functionality (immediate-release, sustained-release, delayed-release), size (Size 000, Size 00, Size 0, Size 1, Size 2, Size 3, Size 4, Size 5), therapeutic application (antibiotic & antibacterial drugs, dietary supplements, antacid & ant flatulent preparations, anti-anaemic preparations, anti-inflammatory drugs, cardiovascular therapy drugs, cough & cold drugs, other therapeutic applications), end user (pharmaceutical industry, nutraceutical industry, cosmetic industry, research laboratories) and region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa).

The scope of the report covers detailed information about major factors such as drivers, restraints, challenges, and opportunities that influence the growth of the empty capsules market. A thorough analysis of key industry players has been conducted to provide insights into their business overview, products, and key strategies, including new product launches, collaborations, and partnership agreements.

Key Benefits of Buying the Report:

The report will assist market leaders and new entrants by providing close estimates of revenue in the overall empty capsules market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain insights to more effectively position their businesses and develop appropriate go-to-market strategies. This report will enable stakeholders to grasp the market's pulse and offer information on the key drivers, restraints, opportunities, and challenges within the market.

The report provides insights on the following pointers:

Analysis of key drivers (growth in nutraceuticals & personalized supplements market, growing focus on pharmaceutical development and subsequent increase in clinical trials, expansion of functional & modified-release capsules, sustainability & regulatory-driven transition, increasing preference for self-medication and OTC drugs, shift toward vegetarian & clean-label capsules) restraints (dietary restrictions associated with gelatin consumption, issues related to safety and efficacy, competition from other drug delivery technologies), opportunities (geographic expansion & localized production in emerging economies, development of biodegradable and sustainable capsules), and challenges (challenges associated with logistics and storage of empty capsules, raw material availability & supply chain dependence)
Product Development/Innovation: Detailed insights on upcoming products, technologies, research & development activities in the empty capsules market
Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
Market Diversification: Exhaustive information about untapped geographies, recent developments, and investments in the empty capsules market
Competitive Assessment: In-depth assessment of market shares, company revenue, growth strategies, and product offerings of leading players. A detailed analysis of the key industry players has been done to provide insights into their key strategies, product launches/approvals, acquisitions, partnerships, agreements, collaborations, expansions, other recent developments, investment and funding activities, brand/product comparative analysis, and vendor valuation and financial metrics of the empty capsules market.

Product Code: PH 2935

1 INTRODUCTION

1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
- 1.3.1 EMPTY CAPSULES MARKET SEGMENTATION & REGIONAL SCOPE
- 1.3.2 INCLUSIONS & EXCLUSIONS
- 1.3.3 YEARS CONSIDERED
- 1.3.4 UNITS CONSIDERED
  - 1.3.4.1 Currency/Value units
  - 1.3.4.2 Volume units
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

2.1 RESEARCH APPROACH
- 2.1.1 SECONDARY DATA
  - 2.1.1.1 Key sources of secondary data
  - 2.1.1.2 Key objectives of secondary research
- 2.1.2 PRIMARY DATA
  - 2.1.2.1 Breakdown of primaries
  - 2.1.2.2 Key objectives of primary research
2.2 MARKET ESTIMATION METHODOLOGY
- 2.2.1 GLOBAL EMPTY CAPSULES MARKET ESTIMATION, 2024
  - 2.2.1.1 Company revenue analysis (bottom-up approach)
  - 2.2.1.2 Volume-based estimation
  - 2.2.1.3 MNM repository analysis
  - 2.2.1.4 Primary research
- 2.2.2 SEGMENTAL MARKET ASSESSMENT (TOP-DOWN APPROACH)
2.3 MARKET GROWTH RATE PROJECTIONS
2.4 DATA TRIANGULATION
2.5 STUDY ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.7 RISK ANALYSIS

3 EXECUTIVE SUMMARY

3.1 KEY INSIGHTS AND MARKET HIGHLIGHTS
3.2 STRATEGIC IMPERATIVES FOR STAKEHOLDERS IN EMPTY CAPSULES MARKET
3.3 DISRUPTIVE TRENDS SHAPING EMPTY CAPSULES MARKET

4 PREMIUM INSIGHTS

4.1 SNAPSHOT: GLOBAL EMPTY CAPSULES MARKET, CAGR, AND FORECAST (2025-2030)
4.2 NORTH AMERICA: EMPTY CAPSULES MARKET, BY TYPE AND COUNTRY (2024)
4.3 EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION (2024)
4.4 EMPTY CAPSULES MARKET, BY END USER (2024)
4.5 EMPTY CAPSULES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET DYNAMICS
- 5.2.1 DRIVERS
  - 5.2.1.1 Increasing demand for nutraceuticals and personalized supplements
  - 5.2.1.2 Growing focus on pharmaceutical development and increase in clinical trials
  - 5.2.1.3 Increased demand for functional and modified-release capsules in pharmaceutical and nutraceutical industries
  - 5.2.1.4 Advancements in capsule delivery technologies
  - 5.2.1.5 Shift toward vegetarian, vegan, and clean-label capsules
  - 5.2.1.6 Growing preference for self-medication and OTC drugs
- 5.2.2 RESTRAINTS
  - 5.2.2.1 Dietary restrictions associated with gelatin consumption
  - 5.2.2.2 Issues related to safety and efficacy of gelatin capsules
  - 5.2.2.3 Competition from alternative drug delivery technologies
- 5.2.3 OPPORTUNITIES
  - 5.2.3.1 Geographic expansion and localized production in emerging economies
  - 5.2.3.2 Development of biodegradable and sustainable capsules in life sciences industry
- 5.2.4 CHALLENGES
  - 5.2.4.1 Challenges associated with logistics and storage of empty capsules
  - 5.2.4.2 Lack of adequate raw material and increased supply chain dependence
5.3 INDUSTRY TRENDS
- 5.3.1 AI-INTEGRATED AND PERSONALIZED DRUG AND SUPPLEMENT FORMULATION AND DOSING
- 5.3.2 ON-DEMAND MANUFACTURING SYSTEMS AND DECENTRALIZED CAPSULE-BASED FORMULATIONS IN CLINICAL TRIALS
- 5.3.3 INTEGRATION OF SMART CAPSULES AND INGESTIBLE SENSORS IN CLINICAL RESEARCH
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
5.5 PRICING ANALYSIS
- 5.5.1 AVERAGE SELLING PRICE TREND OF EMPTY CAPSULES, BY TYPE, 2022-2024
- 5.5.2 AVERAGE SELLING PRICE TREND OF EMPTY CAPSULES, BY REGION, 2022-2024
- 5.5.3 FACTORS IMPACTING EMPTY CAPSULES PRICING
5.6 TECHNOLOGY ANALYSIS
- 5.6.1 KEY TECHNOLOGIES
  - 5.6.1.1 Advanced quality control systems
  - 5.6.1.2 Automated encapsulation machines
- 5.6.2 COMPLEMENTARY TECHNOLOGIES
  - 5.6.2.1 3D printing
  - 5.6.2.2 Enteric capsule technologies
- 5.6.3 ADJACENT TECHNOLOGIES
  - 5.6.3.1 Nanotechnology
  - 5.6.3.2 AI in capsule manufacturing
5.7 VALUE CHAIN ANALYSIS
5.8 ECOSYSTEM ANALYSIS
- 5.8.1 RAW MATERIAL VENDORS
- 5.8.2 PRODUCT PROVIDERS
- 5.8.3 END USERS
- 5.8.4 REGULATORY AUTHORITIES
- 5.8.5 EMERGING BUSINESS MODELS AND ECOSYSTEM SHIFT
5.9 PORTER'S FIVE FORCES ANALYSIS
- 5.9.1 THREAT OF NEW ENTRANTS
- 5.9.2 THREAT OF SUBSTITUTES
- 5.9.3 BARGAINING POWER OF SUPPLIERS
- 5.9.4 BARGAINING POWER OF BUYERS
- 5.9.5 INTENSITY OF COMPETITIVE RIVALRY
5.10 KEY STAKEHOLDERS & BUYING CRITERIA
- 5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 5.10.2 KEY BUYING CRITERIA
- 5.10.3 ADOPTION BARRIER & INTERNAL FRICTION
5.11 PATENT ANALYSIS
- 5.11.1 PATENT METHODOLOGY
- 5.11.2 NUMBER OF PATENTS FILED, BY DOCUMENT TYPE
- 5.11.3 INNOVATION & PATENT APPLICATIONS
- 5.11.4 TOP APPLICANTS
- 5.11.5 INDICATIVE LIST OF PATENTS
5.12 KEY CONFERENCES & EVENTS, 2025-2026
5.13 TRADE ANALYSIS
- 5.13.1 IMPORT AND EXPORT DATA FOR HS CODE 960200
  - 5.13.1.1 Import data for HS code 960200, 2020-2024
  - 5.13.1.2 Export data for HS code 960200, 2020-2024
- 5.13.2 IMPORT AND EXPORT VOLUME FOR HS CODE 960200
  - 5.13.2.1 Import volume for HS code 960200, 2020-2024
  - 5.13.2.2 Export volume for HS code 960200, 2020-2024
5.14 TARRIF DATA & REGULATORY ANALYSIS
- 5.14.1 TARIFF DATA ANALYSIS
- 5.14.2 REGULATORY FRAMEWORK
  - 5.14.2.1 Manufacturing process standards
  - 5.14.2.2 Regulations for capsule supplier change
  - 5.14.2.3 Regulatory information on colorants
- 5.14.3 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 5.14.4 REGULATORY CHALLENGES
- 5.14.5 SUSTAINABILITY IMPACT
5.15 CUSTOMER LANDSCAPE
- 5.15.1 UNMET NEEDS & WHITE SPACES
- 5.15.2 CAPSULE PURCHASE/PROCUREMENT MODELS
- 5.15.3 BUDGET ALLOCATION TREND
- 5.15.4 STRATEGIC ANALYSIS OF GROWTH OPPORTUNITIES
5.16 INVESTMENT & FUNDING SCENARIO
5.17 IMPACT OF AI/GEN AI ON EMPTY CAPSULES MARKET
- 5.17.1 MARKET POTENTIAL OF AI IN EMPTY CAPSULES PRODUCTION
- 5.17.2 AI USE CASES
- 5.17.3 KEY COMPANIES IMPLEMENTING AI
- 5.17.4 FUTURE OF GENERATIVE AI IN EMPTY CAPSULES ECOSYSTEM
5.18 IMPACT OF 2025 TRUMP TARIFF ON EMPTY CAPSULES MARKET
- 5.18.1 INTRODUCTION
- 5.18.2 KEY TARIFF RATES
- 5.18.3 PRICE IMPACT ANALYSIS
- 5.18.4 IMPACT ON COUNTRY/REGION
  - 5.18.4.1 North America
    - 5.18.4.1.1 US
  - 5.18.4.2 Europe
  - 5.18.4.3 Asia Pacific
- 5.18.5 IMPACT ON END-USE INDUSTRIES
  - 5.18.5.1 Pharmaceutical & biotech companies
  - 5.18.5.2 Nutraceutical industry
  - 5.18.5.3 Cosmetic industry
5.19 EMPTY CAPSULES MANUFACTURING PROCESS
- 5.19.1 SOURCING OF RAW MATERIAL
  - 5.19.1.1 Identify source
  - 5.19.1.2 Impact of source variation on product quality
  - 5.19.1.3 Certification for sustainable and ethical sourcing
  - 5.19.1.4 Impact of market dynamics on raw material sourcing
  - 5.19.1.5 Role of industry associations on raw material sourcing
- 5.19.2 PROCESSING
- 5.19.3 QUALITY CONTROL & PACKAGING
5.20 EMPTY CAPSULES PRODUCTION CAPACITY
5.21 INTERCONNECTED MARKET: INSIGHTS ON PHARMACEUTICAL GELATIN MARKET

6 EMPTY CAPSULES MARKET, BY TYPE

6.1 INTRODUCTION
6.2 GELATIN CAPSULES
- 6.2.1 PROVEN SAFETY, VERSATILITY, EASE OF MANUFACTURING, QUICK DISINTEGRATION, AND HIGH BIOAVAILABILITY TO DRIVE ADOPTION
- 6.2.2 GELATIN EMPTY CAPSULES VOLUME MARKET, BY REGION
6.3 NON-GELATIN CAPSULES
- 6.3.1 SHIFT OF CONSUMER DEMAND TOWARD CLEAN-LABEL, VEGAN, AND SUSTAINABLE SOLUTIONS TO PROPEL MARKET GROWTH
- 6.3.2 NON-GELATIN EMPTY CAPSULES VOLUME MARKET, BY REGION

7 EMPTY CAPSULES MARKET, BY RAW MATERIAL

7.1 INTRODUCTION
7.2 GELATIN CAPSULES MARKET, BY RAW MATERIAL
- 7.2.1 PORCINE GELATIN
  - 7.2.1.1 Cost-effectiveness, high availability, and quick dissolving properties to support use in hard capsule production
- 7.2.2 BOVINE-DERIVED GELATIN
  - 7.2.2.1 Reduced cattle slaughter to limit market growth
- 7.2.3 BONEMEAL GELATIN
  - 7.2.3.1 Rising demand for bonemeal capsules in pharmaceutical industry to encourage market growth
- 7.2.4 OTHER GELATIN SOURCES
7.3 NON-GELATIN CAPSULES MARKET, BY RAW MATERIAL
- 7.3.1 HYDROXYPROPYL METHYLCELLULOSE (HPMC)
  - 7.3.1.1 Chemical & thermal stability, faster dissolution, and low brittleness in low humidity to favor market growth
- 7.3.2 PULLULAN & STARCH
  - 7.3.2.1 Increasing demand for transparent, vegan, and non-GMO capsules to accelerate market growth

8 EMPTY CAPSULES MARKET, BY FUNCTIONALITY

8.1 INTRODUCTION
8.2 IMMEDIATE-RELEASE CAPSULES
- 8.2.1 RAPID ABSORPTION, LOW PRODUCTION COST, AND BROAD APPLICATIONS TO AUGMENT MARKET GROWTH
8.3 SUSTAINED-RELEASE CAPSULES
- 8.3.1 CONTROLLED DRUG RELEASE FOR CHRONIC DISEASE MANAGEMENT TO SPUR MARKET GROWTH
8.4 DELAYED-RELEASE CAPSULES
- 8.4.1 DEMAND FOR ENTERIC-COATED CAPSULES AND ADVANCEMENTS IN PH-SENSITIVE POLYMER COATINGS TO DRIVE MARKET

9 EMPTY CAPULES MARKET, BY SIZE

9.1 INTRODUCTION
9.2 SIZE 0
- 9.2.1 RISING DEMAND FOR MID-DOSE FORMULATIONS TO FUEL MAKET GROWTH
9.3 SIZE 00
- 9.3.1 INCREASED NEED FOR ENCAPSULATING SINGLE-DOSE HERBAL EXTRACTS TO BOOST MARKET GROWTH
9.4 SIZE 1
- 9.4.1 NEED FOR COMPACT, LOW-TO-MID DOSE FORMULATIONS WITH HIGH SWALLOWABILITY TO BOOST ADOPTION
9.5 SIZE 2
- 9.5.1 DOSE ACCURACY, COMPATIBILITY WITH DIETARY PREFERENCES, AND STANDARD MANUFACTURING EQUIPMENT TO SPUR MARKET
9.6 SIZE 000
- 9.6.1 POPULARITY OF HIGH-DOSE CAPSULES IN SPORTS NUTRITION, FUNCTIONAL MEDICINES, AND HERBAL FORMULATIONS TO DRIVE MARKET
9.7 SIZE 3
- 9.7.1 NEED FOR PRECISE AND LOW-DOSE DELIVERY TO AUGMENT MARKET GROWTH
9.8 SIZE 4
- 9.8.1 FOCUS ON DOSE PERSONALIZATION AND PATIENT-CENTRIC CARE TO FUEL ADOPTION IN PEDIATRIC DOSING AND GERIATRIC MEDICATIONS
9.9 SIZE 5
- 9.9.1 MINIMAL CAPACITY AND SMALL FOOTPRINT TO BE USEFUL IN SPECIALTY SEGMENTS

10 EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION

10.1 INTRODUCTION
10.2 ANTIBIOTIC & ANTIBACTERIAL DRUGS
- 10.2.1 HIGH INCIDENCE OF INFECTIOUS DISEASES AND FOCUS ON INNOVATIVE CAPSULE FORMULATIONS TO DRIVE MARKET
10.3 DIETARY SUPPLEMENTS
- 10.3.1 HIGH UPTAKE OF MULTIVITAMINS TO BOOST MARKET DEMAND
10.4 ANTACID & ANTIFLATULENT PREPARATIONS
- 10.4.1 POPULARITY OF GENERIC MEDICATIONS AND LIFESTYLE CHANGES IN EMERGING ECONOMIES TO SPUR MARKET GROWTH
10.5 ANTIANEMIC PREPARATIONS
- 10.5.1 RISING PREVALENCE OF ANEMIA TO SUPPORT MARKET FOR IRON & FOLIC ACID DEFICIENCY CAPSULES
10.6 ANTI-INFLAMMATORY DRUGS
- 10.6.1 EXPANSION OF GENERIC THERAPEUTICS MARKET FOR OBESITY TO PROPEL MARKET GROWTH
10.7 CARDIOVASCULAR THERAPY DRUGS
- 10.7.1 SEDENTARY LIFESTYLE AND HIGH PREVALENCE OF DIABETES TO BOOST MARKET GROWTH
10.8 COUGH & COLD DRUGS
- 10.8.1 RISING ENVIRONMENTAL POLLUTION AND INCREASING NUMBER OF PASSIVE SMOKERS TO FAVOR MARKET GROWTH
10.9 OTHER THERAPEUTIC APPLICATIONS

11 EMPTY CAPSULES MARKET, BY END USER

11.1 INTRODUCTION
11.2 PHARMACEUTICAL INDUSTRY
- 11.2.1 INCREASING FOCUS ON ADVANCED DRUG DISCOVERY & DEVELOPMENT TO PROPEL MARKET GROWTH
11.3 NUTRACEUTICAL INDUSTRY
- 11.3.1 GROWING DEMAND FOR DIETARY SUPPLEMENTS TO BOOST MARKET DEMAND
11.4 COSMETIC INDUSTRY
- 11.4.1 RISING FOCUS ON PERSONALIZED BEAUTY AND HOLISTIC WELLNESS TO SUPPORT MARKET GROWTH
11.5 RESEARCH LABORATORIES
- 11.5.1 GROWING FOCUS ON CLINICAL TRIALS TO SUPPORT ADOPTION IN PRECISE DOSING AND PHARMACEUTICAL TESTING

12 EMPTY CAPSULES MARKET, BY REGION

12.1 INTRODUCTION
- 12.1.1 GLOBAL EMPTY CAPSULES MARKET VOLUME
12.2 NORTH AMERICA
- 12.2.1 NORTH AMERICAN EMPTY CAPSULES VOLUME MARKET, BY TYPE
- 12.2.2 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
- 12.2.3 US
  - 12.2.3.1 US to dominate North American empty capsules market during forecast period
- 12.2.4 CANADA
  - 12.2.4.1 Rising per capita healthcare spending and growing elderly population to propel market growth
12.3 EUROPE
- 12.3.1 EUROPEAN EMPTY CAPSULES VOLUME MARKET, BY TYPE
- 12.3.2 MACROECONOMIC OUTLOOK FOR EUROPE
- 12.3.3 GERMANY
  - 12.3.3.1 Rising consumer demand for capsule-based pharma and nutraceutical formulations to aid market growth
- 12.3.4 UK
  - 12.3.4.1 High demand for nutraceuticals and rapid shift toward plant-based lifestyles to augment market growth
- 12.3.5 FRANCE
  - 12.3.5.1 Popularity of self-care trends and regulatory push for plant-based capsules to propel market growth
- 12.3.6 ITALY
  - 12.3.6.1 High R&D spending in pharmaceutical manufacturing industry to support market growth
- 12.3.7 SPAIN
  - 12.3.7.1 Low production costs and consolidation of biotechnology sector to fuel market growth
- 12.3.8 NETHERLANDS
  - 12.3.8.1 Expanding clinical research activity and strong nutraceutical innovation ecosystem to drive market
- 12.3.9 REST OF EUROPE
12.4 ASIA PACIFIC
- 12.4.1 ASIA PACIFIC EMPTY CAPSULES VOLUME MARKET, BY TYPE
- 12.4.2 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
- 12.4.3 CHINA
  - 12.4.3.1 Rapidly growing pharmaceutical, cosmetic, and nutraceutical industries to augment market growth
- 12.4.4 INDIA
  - 12.4.4.1 Surge in demand for dietary supplements and presence of highly skilled medical professionals to favor market growth
- 12.4.5 JAPAN
  - 12.4.5.1 Increased demand for high-quality generic oral drugs to boost market demand
- 12.4.6 SOUTH KOREA
  - 12.4.6.1 Increased government focus on domestic drug production and R&D to support market growth
- 12.4.7 AUSTRALIA
  - 12.4.7.1 Rising incidence of chronic diseases among geriatric population and increasing demand for supplements to fuel market growth
- 12.4.8 NEW ZEALAND
  - 12.4.8.1 Increasing prevalence of lifestyle-related disorders and expanding therapeutic supplement use to propel market growth
- 12.4.9 REST OF ASIA PACIFIC
12.5 LATIN AMERICA
- 12.5.1 LATIN AMERICAN EMPTY CAPSULES VOLUME MARKET, BY TYPE
- 12.5.2 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
- 12.5.3 BRAZIL
  - 12.5.3.1 High export of generics to support market growth
- 12.5.4 MEXICO
  - 12.5.4.1 Well-developed healthcare regulatory environment and increased demand for chronic disease treatment to favor market growth
- 12.5.5 REST OF LATIN AMERICA
12.6 MIDDLE EAST
- 12.6.1 MIDDLE EASTERN EMPTY CAPSULES VOLUME MARKET, BY TYPE
- 12.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST
- 12.6.3 GCC COUNTRIES
  - 12.6.3.1 Saudi Arabia
    - 12.6.3.1.1 Favorable government-led healthcare reforms and increased pharmaceutical production capabilities to aid market growth
  - 12.6.3.2 UAE
    - 12.6.3.2.1 Favorable government strategies and high per capita health expenditure to fuel market growth
  - 12.6.3.3 Rest of GCC Countries
- 12.6.4 REST OF MIDDLE EAST
12.7 AFRICA
- 12.7.1 DEVELOPMENT OF PHARMACEUTICAL SECTOR TO SPUR MARKET GROWTH
- 12.7.2 AFRICAN EMPTY CAPSULES VOLUME MARKET, BY TYPE
- 12.7.3 MACROECONOMIC OUTLOOK FOR AFRICA

13 COMPETITIVE LANDSCAPE

13.1 INTRODUCTION
13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
- 13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN EMPTY CAPSULES MARKET, JANUARY 2022-JULY 2025
13.3 REVENUE ANALYSIS, 2020-2024
13.4 MARKET SHARE ANALYSIS, 2024
13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
- 13.5.1 STARS
- 13.5.2 EMERGING LEADERS
- 13.5.3 PERVASIVE PLAYERS
- 13.5.4 PARTICIPANTS
- 13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
  - 13.5.5.1 Company footprint
  - 13.5.5.2 Region footprint
  - 13.5.5.3 Type footprint
  - 13.5.5.4 Functionality footprint
  - 13.5.5.5 End-user footprint
13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
- 13.6.1 PROGRESSIVE COMPANIES
- 13.6.2 RESPONSIVE COMPANIES
- 13.6.3 DYNAMIC COMPANIES
- 13.6.4 STARTING BLOCKS
- 13.6.5 COMPETITIVE BENCHMARKING
  - 13.6.5.1 Detailed list of key startups/SMEs
  - 13.6.5.2 Competitive benchmarking of startups/SMEs
13.7 COMPANY VALUATION & FINANCIAL METRICS
- 13.7.1 FINANCIAL METRICS
- 13.7.2 COMPANY VALUATION
13.8 BRAND/PRODUCT COMPARISON
13.9 COMPETITIVE SCENARIO
- 13.9.1 PRODUCT LAUNCHES & APPROVALS
- 13.9.2 DEALS
- 13.9.3 EXPANSIONS
- 13.9.4 OTHER DEVELOPMENTS

14 COMPANY PROFILES

14.1 KEY PLAYERS
- 14.1.1 CAPSUGEL (LONZA)
  - 14.1.1.1 Business overview
  - 14.1.1.2 Products offered
  - 14.1.1.3 Recent developments
    - 14.1.1.3.1 Product launches
    - 14.1.1.3.2 Other developments
  - 14.1.1.4 MnM view
    - 14.1.1.4.1 Key strengths
    - 14.1.1.4.2 Strategic choices
    - 14.1.1.4.3 Weaknesses & competitive threats
- 14.1.2 ACG
  - 14.1.2.1 Business overview
  - 14.1.2.2 Products offered
  - 14.1.2.3 Recent developments
    - 14.1.2.3.1 Expansions
    - 14.1.2.3.2 Other developments
  - 14.1.2.4 MnM view
    - 14.1.2.4.1 Key strengths
    - 14.1.2.4.2 Strategic choices
    - 14.1.2.4.3 Weaknesses & competitive threats
- 14.1.3 QUALICAPS (ROQUETTE FRERES)
  - 14.1.3.1 Business overview
  - 14.1.3.2 Products offered
  - 14.1.3.3 Recent developments
    - 14.1.3.3.1 Deals
    - 14.1.3.3.2 Expansions
  - 14.1.3.4 MnM view
    - 14.1.3.4.1 Key strengths
    - 14.1.3.4.2 Strategic choices
    - 14.1.3.4.3 Weaknesses & competitive threats
- 14.1.4 SUHEUNG
  - 14.1.4.1 Business overview
  - 14.1.4.2 Products offered
  - 14.1.4.3 Recent developments
    - 14.1.4.3.1 Product launches & approvals
- 14.1.5 HEALTHCAPS INDIA
  - 14.1.5.1 Business overview
  - 14.1.5.2 Products offered
- 14.1.6 NECTAR LIFESCIENCES LTD.
  - 14.1.6.1 Business overview
  - 14.1.6.2 Products offered
  - 14.1.6.3 Recent developments
    - 14.1.6.3.1 Deals
- 14.1.7 SUNIL HEALTHCARE LIMITED
  - 14.1.7.1 Business overview
  - 14.1.7.2 Products offered
- 14.1.8 NATURAL CAPSULES LIMITED
  - 14.1.8.1 Business overview
  - 14.1.8.2 Products offered
  - 14.1.8.3 Recent developments
    - 14.1.8.3.1 Deals
- 14.1.9 QINGDAO YIQING BIOTECHNOLOGY CO., LTD. (BAOTOU DONGBAO BIO-TECH CO., LTD.)
  - 14.1.9.1 Business overview
  - 14.1.9.2 Products offered
  - 14.1.9.3 Recent developments
    - 14.1.9.3.1 Product launches
- 14.1.10 COMED CHEMICALS LIMITED
  - 14.1.10.1 Business overview
  - 14.1.10.2 Products offered
- 14.1.11 ANHUI HUANGSHAN CAPSULE CO., LTD.
  - 14.1.11.1 Business overview
  - 14.1.11.2 Products offered
- 14.1.12 FORTCAPS (KUMAR ORGANIC PRODUCTS LIMITED)
  - 14.1.12.1 Business overview
  - 14.1.12.2 Products offered
  - 14.1.12.3 Recent developments
    - 14.1.12.3.1 Deals
- 14.1.13 SHANDONG HEALSEE CAPSULE LTD. (SHANDONG HEAD GROUP CO., LTD.)
  - 14.1.13.1 Business overview
  - 14.1.13.2 Products offered
- 14.1.14 CAPSCANADA
  - 14.1.14.1 Business overview
  - 14.1.14.2 Products offered
- 14.1.15 FARMACAPSULAS
  - 14.1.15.1 Business overview
  - 14.1.15.2 Products offered
- 14.1.16 SHANXI GUANGSHENG MEDICINAL CAPSULE CO., LTD.
  - 14.1.16.1 Business overview
  - 14.1.16.2 Products offered
  - 14.1.16.3 Recent developments
    - 14.1.16.3.1 Other developments
- 14.1.17 ERAWAT PHARMA LIMITED
  - 14.1.17.1 Business overview
  - 14.1.17.2 Products offered
14.2 OTHER PLAYERS
- 14.2.1 SAVIOURCAPS
- 14.2.2 SHANXI JC BIOLOGICAL TECHNOLOGY CO.
- 14.2.3 ROXLOR
- 14.2.4 MEDISCA INC.
- 14.2.5 ZHEJIANG YUEXI CAPSULE CO., LTD.
- 14.2.6 SHAOXING KANGKE CAPSULE CO., LTD.
- 14.2.7 ZHEJIANG HUILI CAPSULES CO., LTD.
- 14.2.8 SHAOXING ZHONGYA CAPSULE CO., LTD.
- 14.2.9 SHING LIH FANG ENTERPRISE CO., LTD.
- 14.2.10 LEFANCAPS
- 14.2.11 CHEMCAPS LIMITED
- 14.2.12 BIOCAPS ENTERPRISE
- 14.2.13 SNAIL PHARMA INDUSTRY
- 14.2.14 BRIGHT PHARMA CAPS
- 14.2.15 SHREE PHARMA CAPS
- 14.2.16 HEXIN CAPSULE CO., LTD.
- 14.2.17 WUHAN CARMA TECHNOLOGY CO., LTD.
- 14.2.18 AIPAK PHARMA

15 APPENDIX

15.1 DISCUSSION GUIDE
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
15.3 CUSTOMIZATION OPTIONS
15.4 RELATED REPORTS
15.5 AUTHOR DETAILS

Product Code: PH 2935

List of Tables

TABLE 1 EMPTY CAPSULES MARKET: INCLUSIONS & EXCLUSIONS
TABLE 2 IMPACT ANALYSIS OF SUPPLY- AND DEMAND-SIDE FACTORS
TABLE 3 EMPTY CAPSULES MARKET: RISK ANALYSIS
TABLE 4 EMPTY CAPSULES MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 5 AVERAGE SELLING PRICE TREND OF EMPTY CAPSULES, BY TYPE, 2022-2024 (USD)
TABLE 6 AVERAGE SELLING PRICE TREND OF EMPTY CAPSULES, BY REGION, 2022-2024 (USD)
TABLE 7 EMPTY CAPSULES MARKET: RAW MATERIAL VENDORS
TABLE 8 EMPTY CAPSULES MARKET: PRODUCT PROVIDERS
TABLE 9 EMPTY CAPSULES MARKET: END USERS
TABLE 10 EMPTY CAPSULES MARKET: REGULATORY AUTHORITIES
TABLE 11 EMERGING BUSINESS MODELS AND TARGET SEGMENTS IN EMPTY CAPSULES MARKET
TABLE 12 EMPTY CAPSULES MARKET: PORTER'S FIVE FORCES
TABLE 13 KEY STAKEHOLDERS ACROSS VARIOUS END-USE INDUSTRIES INFLUENCING BUYING PROCESS
TABLE 14 KEY BUYING CRITERIA FOR EMPTY CAPSULES, BY END USER
TABLE 15 EMPTY CAPSULES: ADOPTION BARRIER & INTERNAL FRICTION
TABLE 16 NUMBER OF PATENTS FILED, BY DOCUMENT TYPE, 2014-2024
TABLE 17 TOP 10 PATENT OWNERS/APPLICANTS IN EMPTY CAPSULES MARKET, 2014-2024
TABLE 18 INDICATIVE LIST OF PATENTS IN EMPTY CAPSULES MARKET, 2023-2025
TABLE 19 EMPTY CAPSULES MARKET: LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025-DECEMBER 2026
TABLE 20 IMPORT DATA FOR HS CODE 960200, 2020-2024 (USD THOUSAND)
TABLE 21 EXPORT DATA FOR HS CODE 960200, 2020-2024 (USD THOUSAND)
TABLE 22 IMPORT VOLUME FOR HS CODE 960200, 2020-2024 (TONS)
TABLE 23 EXPORT VOLUME FOR HS CODE 960200, 2020-2024 (TONS)
TABLE 24 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 25 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 26 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 27 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 28 STARTEGIC ANALYSIS OF GROWTH OPPORTUNITIES IN EMPTY CAPSULES MARKET
TABLE 29 KEY COMPANIES IMPLEMENTING AI IN EMPTY CAPSULES MARKET
TABLE 30 EMPTY CAPSULES-RELATED TARIFF REVISION
TABLE 31 KEY PLAYERS AND THEIR INSTALLED ANNUAL PRODUCTION CAPACITY IN EMPTY CAPSULES MARKET
TABLE 32 EMPTY CAPSULES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 33 EMPTY CAPSULES MARKET, BY TYPE, 2023-2030 (BILLION UNITS)
TABLE 34 GELATIN EMPTY CAPSULES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 35 NORTH AMERICA: GELATIN EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 36 EUROPE: GELATIN EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 37 ASIA PACIFIC: GELATIN EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 38 LATIN AMERICA: GELATIN EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 39 MIDDLE EAST: GELATIN EMPTY CAPSULES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 40 GCC COUNTRIES: GELATIN EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 41 GELATIN EMPTY CAPSULES MARKET, BY REGION, 2023-2030 (BILLION UNITS)
TABLE 42 NON-GELATIN EMPTY CAPSULES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 43 NORTH AMERICA: NON-GELATIN EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 44 EUROPE: NON-GELATIN EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 45 ASIA PACIFIC: NON-GELATIN EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 46 LATIN AMERICA: NON-GELATIN EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 47 MIDDLE EAST: NON-GELATIN EMPTY CAPSULES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 48 GCC COUNTRIES: NON-GELATIN EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 49 NON-GELATIN EMPTY CAPSULES MARKET, BY REGION, 2023-2030 (BILLION UNITS)
TABLE 50 GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 51 PORCINE GELATIN CAPSULES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 52 NORTH AMERICA: PORCINE GELATIN CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 53 EUROPE: PORCINE GELATIN CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 54 ASIA PACIFIC: PORCINE GELATIN CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 55 LATIN AMERICA: PORCINE GELATIN CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 56 MIDDLE EAST: PORCINE GELATIN CAPSULES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 57 GCC COUNTRIES: PORCINE GELATIN CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 58 BOVINE-DERIVED GELATIN CAPSULES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 59 NORTH AMERICA: BOVINE-DERIVED GELATIN CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 60 EUROPE: BOVINE-DERIVED GELATIN CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 61 ASIA PACIFIC: BOVINE-DERIVED GELATIN CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 62 LATIN AMERICA: BOVINE-DERIVED GELATIN CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 63 MIDDLE EAST: BOVINE-DERIVED GELATIN CAPSULES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 64 GCC COUNTRIES: BOVINE-DERIVED GELATIN CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 65 BONEMEAL GELATIN CAPSULES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 66 NORTH AMERICA: BONEMEAL GELATIN CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 67 EUROPE: BONEMEAL GELATIN CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 68 ASIA PACIFIC: BONEMEAL GELATIN CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 69 LATIN AMERICA: BONEMEAL GELATIN CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 70 MIDDLE EAST: BONEMEAL GELATIN CAPSULES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 71 GCC COUNTRIES: BONEMEAL GELATIN CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 72 OTHER GELATIN SOURCES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 73 NORTH AMERICA: OTHER GELATIN SOURCES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 74 EUROPE: OTHER GELATIN SOURCES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 75 ASIA PACIFIC: OTHER GELATIN SOURCES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 76 LATIN AMERICA: OTHER GELATIN SOURCES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 77 MIDDLE EAST: OTHER GELATIN SOURCES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 78 GCC COUNTRIES: OTHER GELATIN CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 79 NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 80 HYDROXYPROPYL METHYLCELLULOSE (HPMC) MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 81 NORTH AMERICA: HYDROXYPROPYL METHYLCELLULOSE (HPMC) MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 82 EUROPE: HYDROXYPROPYL METHYLCELLULOSE (HPMC) MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 83 ASIA PACIFIC: HYDROXYPROPYL METHYLCELLULOSE (HPMC) MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 84 LATIN AMERICA: HYDROXYPROPYL METHYLCELLULOSE (HPMC) MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 85 MIDDLE EAST: HYDROXYPROPYL METHYLCELLULOSE (HPMC) MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 86 GCC COUNTRIES: HYDROXYPROPYL METHYLCELLULOSE (HPMC) MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 87 PULLULAN & STARCH MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 88 NORTH AMERICA: PULLULAN & STARCH MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 89 EUROPE: PULLULAN & STARCH MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 90 ASIA PACIFIC: PULLULAN & STARCH MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 91 LATIN AMERICA: PULLULAN & STARCH MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 92 MIDDLE EAST: PULLULAN & STARCH MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 93 GCC COUNTRIES: PULLULAN & STARCH MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 94 EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023-2030 (USD MILLION)
TABLE 95 IMMEDIATE-RELEASE EMPTY CAPSULES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 96 NORTH AMERICA: IMMEDIATE-RELEASE EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 97 EUROPE: IMMEDIATE-RELEASE EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 98 ASIA PACIFIC: IMMEDIATE-RELEASE EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 99 LATIN AMERICA: IMMEDIATE-RELEASE EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 100 MIDDLE EAST: IMMEDIATE-RELEASE EMPTY CAPSULES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 101 GCC COUNTRIES: IMMEDIATE-RELEASE EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 102 SUSTAINED-RELEASE EMPTY CAPSULES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 103 NORTH AMERICA: SUSTAINED-RELEASE EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 104 EUROPE: SUSTAINED-RELEASE EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 105 ASIA PACIFIC: SUSTAINED-RELEASE EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 106 LATIN AMERICA: SUSTAINED-RELEASE EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 107 MIDDLE EAST: SUSTAINED-RELEASE EMPTY CAPSULES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 108 GCC COUNTRIES: SUSTAINED-RELEASE EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 109 DELAYED-RELEASE EMPTY CAPSULES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 110 NORTH AMERICA: DELAYED-RELEASE EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 111 EUROPE: DELAYED-RELEASE EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 112 ASIA PACIFIC: DELAYED-RELEASE EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 113 LATIN AMERICA: DELAYED-RELEASE EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 114 MIDDLE EAST: DELAYED-RELEASE EMPTY CAPSULES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 115 GCC COUNTRIES: DELAYED-RELEASE EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 116 EMPTY CAPSULES MARKET, BY SIZE, 2023-2030 (USD MILLION)
TABLE 117 SIZE 0 EMPTY CAPSULES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 118 NORTH AMERICA: SIZE 0 EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 119 EUROPE: SIZE 0 EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 120 ASIA PACIFIC: SIZE 0 EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 121 LATIN AMERICA: SIZE 0 EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 122 MIDDLE EAST: SIZE 0 EMPTY CAPSULES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 123 GCC COUNTRIES: SIZE 0 EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 124 SIZE 00 EMPTY CAPSULES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 125 NORTH AMERICA: SIZE 00 EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 126 EUROPE: SIZE 00 EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 127 ASIA PACIFIC: SIZE 00 EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 128 LATIN AMERICA: SIZE 00 EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 129 MIDDLE EAST: SIZE 00 EMPTY CAPSULES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 130 GCC COUNTRIES: SIZE 00 EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 131 SIZE 1 EMPTY CAPSULES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 132 NORTH AMERICA: SIZE 1 EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 133 EUROPE: SIZE 1 EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 134 ASIA PACIFIC: SIZE 1 EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 135 LATIN AMERICA: SIZE 1 EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 136 MIDDLE EAST: SIZE 1 EMPTY CAPSULES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 137 GCC COUNTRIES: SIZE 1 EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 138 SIZE 2 EMPTY CAPSULES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 139 NORTH AMERICA: SIZE 2 EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 140 EUROPE: SIZE 2 EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 141 ASIA PACIFIC: SIZE 2 EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 142 LATIN AMERICA: SIZE 2 EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 143 MIDDLE EAST: SIZE 2 EMPTY CAPSULES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 144 GCC COUNTRIES: SIZE 2 EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 145 SIZE 000 EMPTY CAPSULES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 146 NORTH AMERICA: SIZE 000 EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 147 EUROPE: SIZE 000 EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 148 ASIA PACIFIC: SIZE 000 EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 149 LATIN AMERICA: SIZE 000 EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 150 MIDDLE EAST: SIZE 000 EMPTY CAPSULES MARKET, BY REGION 2023-2030 (USD MILLION)
TABLE 151 GCC COUNTRIES: SIZE 000 EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 152 SIZE 3 EMPTY CAPSULES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 153 NORTH AMERICA: SIZE 3 EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 154 EUROPE: SIZE 3 EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 155 ASIA PACIFIC: SIZE 3 EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 156 LATIN AMERICA: SIZE 3 EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 157 MIDDLE EAST: SIZE 3 EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 158 GCC COUNTRIES: SIZE 3 EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 159 SIZE 4 EMPTY CAPSULES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 160 NORTH AMERICA: SIZE 4 EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 161 EUROPE: SIZE 4 EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 162 ASIA PACIFIC: SIZE 4 EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 163 LATIN AMERICA: SIZE 4 EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 164 MIDDLE EAST: SIZE 4 EMPTY CAPSULES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 165 GCC COUNTRIES: SIZE 4 EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 166 SIZE 5 EMPTY CAPSULES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 167 NORTH AMERICA: SIZE 5 EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 168 EUROPE: SIZE 5 EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 169 ASIA PACIFIC: SIZE 5 EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 170 LATIN AMERICA: SIZE 5 EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 171 MIDDLE EAST: SIZE 5 EMPTY Y CAPSULES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 172 GCC COUNTRIES: SIZE 5 EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 173 EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023-2030 (USD MILLION)
TABLE 174 EMPTY CAPSULES MARKET FOR ANTIBIOTIC & ANTIBACTERIAL DRUGS, BY REGION, 2023-2030 (USD MILLION)
TABLE 175 NORTH AMERICA: EMPTY CAPSULES MARKET FOR ANTIBIOTIC & ANTIBACTERIAL DRUGS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 176 EUROPE: EMPTY CAPSULES MARKET FOR ANTIBIOTIC & ANTIBACTERIAL DRUGS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 177 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR ANTIBIOTIC & ANTIBACTERIAL DRUGS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 178 LATIN AMERICA: EMPTY CAPSULES MARKET FOR ANTIBIOTIC & ANTIBACTERIAL DRUGS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 179 MIDDLE EAST: EMPTY CAPSULES MARKET FOR ANTIBIOTIC & ANTIBACTERIAL DRUGS, BY REGION, 2023-2030 (USD MILLION)
TABLE 180 GCC COUNTRIES: EMPTY CAPSULES MARKET FOR ANTIBIOTIC & ANTIBACTERIAL DRUGS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 181 EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS, BY REGION, 2023-2030 (USD MILLION)
TABLE 182 NORTH AMERICA: EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 183 EUROPE: EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 184 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 185 LATIN AMERICA: EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 186 MIDDLE EAST: EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS, BY REGION, 2023-2030 (USD MILLION)
TABLE 187 GCC COUNTRIES: EMPTY CAPSULES MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 188 EMPTY CAPSULES MARKET FOR ANTACID & ANTIFLATULENT PREPARATIONS, BY REGION, 2023-2030 (USD MILLION)
TABLE 189 NORTH AMERICA: EMPTY CAPSULES MARKET FOR ANTACID & ANTIFLATULENT PREPARATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 190 EUROPE: EMPTY CAPSULES MARKET FOR ANTACID & ANTIFLATULENT PREPARATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 191 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR ANTACID & ANTIFLATULENT PREPARATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 192 LATIN AMERICA: EMPTY CAPSULES MARKET FOR ANTACID & ANTIFLATULENT PREPARATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 193 MIDDLE EAST: EMPTY CAPSULES MARKET FOR ANTACID & ANTIFLATULENT PREPARATIONS, BY REGION, 2023-2030 (USD MILLION)
TABLE 194 GCC COUNTRIES: EMPTY CAPSULES MARKET FOR ANTACID & ANTIFLATULENT PREPARATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 195 EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS, BY REGION, 2023-2030 (USD MILLION)
TABLE 196 NORTH AMERICA: EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 197 EUROPE: EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 198 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 199 LATIN AMERICA: EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 200 MIDDLE EAST: EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS, BY REGION, 2023-2030 (USD MILLION)
TABLE 201 GCC COUNTRIES: EMPTY CAPSULES MARKET FOR ANTIANEMIC PREPARATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 202 EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS, BY REGION, 2023-2030 (USD MILLION)
TABLE 203 NORTH AMERICA: EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 204 EUROPE: EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 205 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 206 LATIN AMERICA: EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 207 MIDDLE EAST: EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS, BY REGION, 2023-2030 (USD MILLION)
TABLE 208 GCC COUNTRIES: EMPTY CAPSULES MARKET FOR ANTI-INFLAMMATORY DRUGS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 209 EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY REGION, 2023-2030 (USD MILLION)
TABLE 210 NORTH AMERICA: EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 211 EUROPE: EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 212 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 213 LATIN AMERICA: EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 214 MIDDLE EAST: EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY REGION, 2023-2030 (USD MILLION)
TABLE 215 GCC COUNTRIES: EMPTY CAPSULES MARKET FOR CARDIOVASCULAR THERAPY DRUGS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 216 EMPTY CAPSULES MARKET FOR COUGH & COLD DRUGS, BY REGION, 2023-2030 (USD MILLION)
TABLE 217 NORTH AMERICA: EMPTY CAPSULES MARKET FOR COUGH & COLD DRUGS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 218 EUROPE: EMPTY CAPSULES MARKET FOR COUGH & COLD DRUGS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 219 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR COUGH & COLD DRUGS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 220 LATIN AMERICA: EMPTY CAPSULES MARKET FOR COUGH & COLD DRUGS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 221 MIDDLE EAST: EMPTY CAPSULES MARKET FOR COUGH & COLD DRUGS, BY REGION, 2023-2030 (USD MILLION)
TABLE 222 GCC COUNTRIES: EMPTY CAPSULES MARKET FOR COUGH & COLD DRUGS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 223 EMPTY CAPSULES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY REGION, 2023-2030 (USD MILLION)
TABLE 224 NORTH AMERICA: EMPTY CAPSULES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 225 EUROPE: EMPTY CAPSULES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 226 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 227 LATIN AMERICA: EMPTY CAPSULES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 228 MIDDLE EAST: EMPTY CAPSULES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY REGION, 2023-2030 (USD MILLION)
TABLE 229 GCC COUNTRIES: EMPTY CAPSULES MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 230 EMPTY CAPSULES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 231 EMPTY CAPSULES MARKET FOR PHARMACEUTICAL INDUSTRY, BY REGION, 2023-2030 (USD MILLION)
TABLE 232 NORTH AMERICA: EMPTY CAPSULES MARKET FOR PHARMACEUTICAL INDUSTRY, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 233 EUROPE: EMPTY CAPSULES MARKET FOR PHARMACEUTICAL INDUSTRY, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 234 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR PHARMACEUTICAL INDUSTRY, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 235 LATIN AMERICA: EMPTY CAPSULES MARKET FOR PHARMACEUTICAL INDUSTRY, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 236 MIDDLE EAST: EMPTY CAPSULES MARKET FOR PHARMACEUTICAL INDUSTRY, BY REGION, 2023-2030 (USD MILLION)
TABLE 237 GCC COUNTRIES: EMPTY CAPSULES MARKET FOR PHARMACEUTICAL INDUSTRY, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 238 EMPTY CAPSULES MARKET FOR NUTRACEUTICAL INDUSTRY, BY REGION, 2023-2030 (USD MILLION)
TABLE 239 NORTH AMERICA: EMPTY CAPSULES MARKET FOR NUTRACEUTICAL INDUSTRY, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 240 EUROPE: EMPTY CAPSULES MARKET FOR NUTRACEUTICAL INDUSTRY, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 241 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR NUTRACEUTICAL INDUSTRY, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 242 LATIN AMERICA: EMPTY CAPSULES MARKET FOR NUTRACEUTICAL INDUSTRY, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 243 MIDDLE EAST: EMPTY CAPSULES MARKET FOR NUTRACEUTICAL INDUSTRY, BY REGION, 2023-2030 (USD MILLION)
TABLE 244 GCC COUNTRIES: EMPTY CAPSULES MARKET FOR NUTRACEUTICAL INDUSTRY, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 245 EMPTY CAPSULES MARKET FOR COSMETIC INDUSTRY, BY REGION, 2023-2030 (USD MILLION)
TABLE 246 NORTH AMERICA: EMPTY CAPSULES MARKET FOR COSMETIC INDUSTRY, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 247 EUROPE: EMPTY CAPSULES MARKET FOR COSMETIC INDUSTRY, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 248 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR COSMETIC INDUSTRY, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 249 LATIN AMERICA: EMPTY CAPSULES MARKET FOR COSMETIC INDUSTRY, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 250 MIDDLE EAST: EMPTY CAPSULES MARKET FOR COSMETIC INDUSTRY, BY REGION, 2023-2030 (USD MILLION)
TABLE 251 GCC COUNTRIES: EMPTY CAPSULES MARKET FOR COSMETIC INDUSTRY, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 252 EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES, BY REGION, 2023-2030 (USD MILLION)
TABLE 253 NORTH AMERICA: EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 254 EUROPE: EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 255 ASIA PACIFIC: EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 256 LATIN AMERICA: EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 257 MIDDLE EAST: EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES, BY REGION, 2023-2030 (USD MILLION)
TABLE 258 GCC COUNTRIES: EMPTY CAPSULES MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 259 EMPTY CAPSULES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 260 EMPTY CAPSULES MARKET, BY REGION, 2023-2030 (BILLION UNITS)
TABLE 261 NORTH AMERICA: EMPTY CAPSULES MARKET, BY TYPE, 2023-2030 (BILLION UNITS)
TABLE 262 NORTH AMERICA: KEY MACROINDICATORS
TABLE 263 NORTH AMERICA: EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 264 NORTH AMERICA: EMPTY CAPSULES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 265 NORTH AMERICA: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 266 NORTH AMERICA: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 267 NORTH AMERICA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023-2030 (USD MILLION)
TABLE 268 NORTH AMERICA: EMPTY CAPSULES MARKET, BY SIZE, 2023-2030 (USD MILLION)
TABLE 269 NORTH AMERICA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023-2030 (USD MILLION)
TABLE 270 NORTH AMERICA: EMPTY CAPSULES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 271 US: EMPTY CAPSULES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 272 US: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 273 US: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 274 US: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023-2030 (USD MILLION)
TABLE 275 US: EMPTY CAPSULES MARKET, BY SIZE, 2023-2030 (USD MILLION)
TABLE 276 US: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023-2030 (USD MILLION)
TABLE 277 US: EMPTY CAPSULES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 278 CANADA: EMPTY CAPSULES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 279 CANADA: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 280 CANADA: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 281 CANADA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023-2030 (USD MILLION)
TABLE 282 CANADA: EMPTY CAPSULES MARKET, BY SIZE, 2023-2030 (USD MILLION)
TABLE 283 CANADA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023-2030 (USD MILLION)
TABLE 284 CANADA: EMPTY CAPSULES MARKET, BY END USER, 2023-2030 (USD MILLION)

List of Figures

TABLE 285 COMPARATIVE ANALYSIS OF GENERIC PENETRATION AMONG EUROPEAN COUNTRIES, BY VOLUME, 2025
TABLE 286 EUROPE: EMPTY CAPSULES MARKET, BY TYPE, 2023-2030 (BILLION UNITS)
TABLE 287 EUROPE: KEY MACROINDICATORS
TABLE 288 EUROPE: EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 289 EUROPE: EMPTY CAPSULES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 290 EUROPE: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 291 EUROPE: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 292 EUROPE: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023-2030 (USD MILLION)
TABLE 293 EUROPE: EMPTY CAPSULES MARKET, BY SIZE, 2023-2030 (USD MILLION)
TABLE 294 EUROPE: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023-2030 (USD MILLION)
TABLE 295 EUROPE: EMPTY CAPSULES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 296 GERMANY: EMPTY CAPSULES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 297 GERMANY: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 298 GERMANY: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 299 GERMANY: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023-2030 (USD MILLION)
TABLE 300 GERMANY: EMPTY CAPSULES MARKET, BY SIZE, 2023-2030 (USD MILLION)
TABLE 301 GERMANY: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023-2030 (USD MILLION)
TABLE 302 GERMANY: EMPTY CAPSULES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 303 UK: EMPTY CAPSULES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 304 UK: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 305 UK: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 306 UK: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023-2030 (USD MILLION)
TABLE 307 UK: EMPTY CAPSULES MARKET, BY SIZE, 2023-2030 (USD MILLION)
TABLE 308 UK: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023-2030 (USD MILLION)
TABLE 309 UK: EMPTY CAPSULES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 310 FRANCE: EMPTY CAPSULES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 311 FRANCE: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 312 FRANCE: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 313 FRANCE: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023-2030 (USD MILLION)
TABLE 314 FRANCE: EMPTY CAPSULES MARKET, BY SIZE, 2023-2030 (USD MILLION)
TABLE 315 FRANCE: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023-2030 (USD MILLION)
TABLE 316 FRANCE: EMPTY CAPSULES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 317 ITALY: EMPTY CAPSULES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 318 ITALY: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 319 ITALY: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 320 ITALY: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023-2030 (USD MILLION)
TABLE 321 ITALY: EMPTY CAPSULES MARKET, BY SIZE, 2023-2030 (USD MILLION)
TABLE 322 ITALY: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023-2030 (USD MILLION)
TABLE 323 ITALY: EMPTY CAPSULES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 324 SPAIN: EMPTY CAPSULES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 325 SPAIN: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 326 SPAIN: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 327 SPAIN: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023-2030 (USD MILLION)
TABLE 328 SPAIN: EMPTY CAPSULES MARKET, BY SIZE, 2023-2030 (USD MILLION)
TABLE 329 SPAIN: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023-2030 (USD MILLION)
TABLE 330 SPAIN: EMPTY CAPSULES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 331 NETHERLANDS: EMPTY CAPSULES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 332 NETHERLANDS: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 333 NETHERLANDS: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 334 NETHERLANDS: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023-2030 (USD MILLION)
TABLE 335 NETHERLANDS: EMPTY CAPSULES MARKET, BY SIZE, 2023-2030 (USD MILLION)
TABLE 336 NETHERLANDS: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023-2030 (USD MILLION)
TABLE 337 NETHERLANDS: EMPTY CAPSULES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 338 REST OF EUROPE: EMPTY CAPSULES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 339 REST OF EUROPE: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 340 REST OF EUROPE: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 341 REST OF EUROPE: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023-2030 (USD MILLION)
TABLE 342 REST OF EUROPE: EMPTY CAPSULES MARKET, BY SIZE, 2023-2030 (USD MILLION)
TABLE 343 REST OF EUROPE: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023-2030 (USD MILLION)
TABLE 344 REST OF EUROPE: EMPTY CAPSULES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 345 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY TYPE, 2023-2030 (BILLION UNITS)
TABLE 346 ASIA PACIFIC: KEY MACROINDICATORS
TABLE 347 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 348 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 349 ASIA PACIFIC: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 350 ASIA PACIFIC: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 351 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023-2030 (USD MILLION)
TABLE 352 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY SIZE, 2023-2030 (USD MILLION)
TABLE 353 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023-2030 (USD MILLION)
TABLE 354 ASIA PACIFIC: EMPTY CAPSULES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 355 CHINA: EMPTY CAPSULES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 356 CHINA: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 357 CHINA: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 358 CHINA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023-2030 (USD MILLION)
TABLE 359 CHINA: EMPTY CAPSULES MARKET, BY SIZE, 2023-2030 (USD MILLION)
TABLE 360 CHINA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023-2030 (USD MILLION)
TABLE 361 CHINA: EMPTY CAPSULES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 362 INDIA: EMPTY CAPSULES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 363 INDIA: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 364 INDIA: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 365 INDIA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023-2030 (USD MILLION)
TABLE 366 INDIA: EMPTY CAPSULES MARKET, BY SIZE, 2023-2030 (USD MILLION)
TABLE 367 INDIA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023-2030 (USD MILLION)
TABLE 368 INDIA: EMPTY CAPSULES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 369 JAPAN: EMPTY CAPSULES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 370 JAPAN: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 371 JAPAN: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 372 JAPAN: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023-2030 (USD MILLION)
TABLE 373 JAPAN: EMPTY CAPSULES MARKET, BY SIZE, 2023-2030 (USD MILLION)
TABLE 374 JAPAN: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023-2030 (USD MILLION)
TABLE 375 JAPAN: EMPTY CAPSULES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 376 SOUTH KOREA: EMPTY CAPSULES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 377 SOUTH KOREA: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 378 SOUTH KOREA: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 379 SOUTH KOREA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023-2030 (USD MILLION)
TABLE 380 SOUTH KOREA: EMPTY CAPSULES MARKET, BY SIZE, 2023-2030 (USD MILLION)
TABLE 381 SOUTH KOREA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023-2030 (USD MILLION)
TABLE 382 SOUTH KOREA: EMPTY CAPSULES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 383 AUSTRALIA: EMPTY CAPSULES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 384 AUSTRALIA: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 385 AUSTRALIA: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 386 AUSTRALIA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023-2030 (USD MILLION)
TABLE 387 AUSTRALIA: EMPTY CAPSULES MARKET, BY SIZE, 2023-2030 (USD MILLION)
TABLE 388 AUSTRALIA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023-2030 (USD MILLION)
TABLE 389 AUSTRALIA: EMPTY CAPSULES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 390 NEW ZEALAND: EMPTY CAPSULES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 391 NEW ZEALAND: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 392 NEW ZEALAND: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 393 NEW ZEALAND: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023-2030 (USD MILLION)
TABLE 394 NEW ZEALAND: EMPTY CAPSULES MARKET, BY SIZE, 2023-2030 (USD MILLION)
TABLE 395 NEW ZEALAND: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023-2030 (USD MILLION)
TABLE 396 NEW ZEALAND: EMPTY CAPSULES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 397 REST OF ASIA PACIFIC: EMPTY CAPSULES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 398 REST OF ASIA PACIFIC: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 399 REST OF ASIA PACIFIC: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 400 REST OF ASIA PACIFIC: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023-2030 (USD MILLION)
TABLE 401 REST OF ASIA PACIFIC: EMPTY CAPSULES MARKET, BY SIZE, 2023-2030 (USD MILLION)
TABLE 402 REST OF ASIA PACIFIC: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023-2030 (USD MILLION)
TABLE 403 REST OF ASIA PACIFIC: EMPTY CAPSULES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 404 LATIN AMERICA: EMPTY CAPSULES MARKET, BY TYPE, 2023-2030 (BILLION UNITS)
TABLE 405 LATIN AMERICA: KEY MACROINDICATORS
TABLE 406 LATIN AMERICA: EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 407 LATIN AMERICA: EMPTY CAPSULES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 408 LATIN AMERICA: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 409 LATIN AMERICA: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 410 LATIN AMERICA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023-2030 (USD MILLION)
TABLE 411 LATIN AMERICA: EMPTY CAPSULES MARKET, BY SIZE, 2023-2030 (USD MILLION)
TABLE 412 LATIN AMERICA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023-2030 (USD MILLION)
TABLE 413 LATIN AMERICA: EMPTY CAPSULES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 414 BRAZIL: EMPTY CAPSULES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 415 BRAZIL: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 416 BRAZIL: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 417 BRAZIL: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023-2030 (USD MILLION)
TABLE 418 BRAZIL: EMPTY CAPSULES MARKET, BY SIZE, 2023-2030 (USD MILLION)
TABLE 419 BRAZIL: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023-2030 (USD MILLION)
TABLE 420 BRAZIL: EMPTY CAPSULES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 421 MEXICO: EMPTY CAPSULES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 422 MEXICO: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 423 MEXICO: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 424 MEXICO: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023-2030 (USD MILLION)
TABLE 425 MEXICO: EMPTY CAPSULES MARKET, BY SIZE, 2023-2030 (USD MILLION)
TABLE 426 MEXICO: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023-2030 (USD MILLION)
TABLE 427 MEXICO: EMPTY CAPSULES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 428 REST OF LATIN AMERICA: EMPTY CAPSULES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 429 REST OF LATIN AMERICA: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 430 REST OF LATIN AMERICA: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 431 REST OF LATIN AMERICA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023-2030 (USD MILLION)
TABLE 432 REST OF LATIN AMERICA: EMPTY CAPSULES MARKET, BY SIZE, 2023-2030 (USD MILLION)
TABLE 433 REST OF LATIN AMERICA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023-2030 (USD MILLION)
TABLE 434 REST OF LATIN AMERICA: EMPTY CAPSULES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 435 MIDDLE EAST: EMPTY CAPSULES MARKET, BY TYPE, 2023-2030 (BILLION UNITS)
TABLE 436 MIDDLE EAST: KEY MACROINDICATORS
TABLE 437 MIDDLE EAST: EMPTY CAPSULES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 438 MIDDLE EAST: EMPTY CAPSULES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 439 MIDDLE EAST: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 440 MIDDLE EAST: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 441 MIDDLE EAST: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023-2030 (USD MILLION)
TABLE 442 MIDDLE EAST: EMPTY CAPSULES MARKET, BY SIZE, 2023-2030 (USD MILLION)
TABLE 443 MIDDLE EAST: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023-2030 (USD MILLION)
TABLE 444 MIDDLE EAST: EMPTY CAPSULES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 445 GCC COUNTRIES: EMPTY CAPSULES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 446 GCC COUNTRIES: EMPTY CAPSULES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 447 GCC COUNTRIES: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 448 GCC COUNTRIES: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 449 GCC COUNTRIES: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023-2030 (USD MILLION)
TABLE 450 GCC COUNTRIES: EMPTY CAPSULES MARKET, BY SIZE, 2023-2030 (USD MILLION)
TABLE 451 GCC COUNTRIES: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023-2030 (USD MILLION)
TABLE 452 GCC COUNTRIES: EMPTY CAPSULES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 453 SAUDI ARABIA: EMPTY CAPSULES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 454 SAUDI ARABIA: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 455 SAUDI ARABIA: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 456 SAUDI ARABIA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023-2030 (USD MILLION)
TABLE 457 SAUDI ARABIA: EMPTY CAPSULES MARKET, BY SIZE, 2023-2030 (USD MILLION)
TABLE 458 SAUDI ARABIA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023-2030 (USD MILLION)
TABLE 459 SAUDI ARABIA: EMPTY CAPSULES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 460 UAE: EMPTY CAPSULES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 461 UAE: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 462 UAE: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 463 UAE: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023-2030 (USD MILLION)
TABLE 464 UAE: EMPTY CAPSULES MARKET, BY SIZE, 2023-2030 (USD MILLION)
TABLE 465 UAE: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023-2030 (USD MILLION)
TABLE 466 UAE: EMPTY CAPSULES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 467 REST OF GCC COUNTRIES: EMPTY CAPSULES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 468 REST OF GCC COUNTRIES: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 469 REST OF GCC COUNTRIES: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 470 REST OF GCC COUNTRIES: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023-2030 (USD MILLION)
TABLE 471 REST OF GCC COUNTRIES: EMPTY CAPSULES MARKET, BY SIZE, 2023-2030 (USD MILLION)
TABLE 472 REST OF GCC COUNTRIES: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023-2030 (USD MILLION)
TABLE 473 REST OF GCC COUNTRIES: EMPTY CAPSULES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 474 REST OF MIDDLE EAST: EMPTY CAPSULES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 475 REST OF MIDDLE EAST: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 476 REST OF MIDDLE EAST: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 477 REST OF MIDDLE EAST: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023-2030 (USD MILLION)
TABLE 478 REST OF MIDDLE EAST: EMPTY CAPSULES MARKET, BY SIZE, 2023-2030 (USD MILLION)
TABLE 479 REST OF MIDDLE EAST: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023-2030 (USD MILLION)
TABLE 480 REST OF MIDDLE EAST: EMPTY CAPSULES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 481 AFRICA: EMPTY CAPSULES MARKET, BY TYPE, 2023-2030 (BILLION UNITS)
TABLE 482 AFRICA: KEY MACROINDICATORS
TABLE 483 AFRICA: EMPTY CAPSULES MARKET, BY TYPE, 2023-2030 (USD MILLION)
TABLE 484 AFRICA: GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 485 AFRICA: NON-GELATIN EMPTY CAPSULES MARKET, BY RAW MATERIAL, 2023-2030 (USD MILLION)
TABLE 486 AFRICA: EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2023-2030 (USD MILLION)
TABLE 487 AFRICA: EMPTY CAPSULES MARKET, BY SIZE, 2023-2030 (USD MILLION)
TABLE 488 AFRICA: EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2023-2030 (USD MILLION)
TABLE 489 AFRICA: EMPTY CAPSULES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 490 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN EMPTY CAPSULES MARKET, JANUARY 2022-JULY 2025
TABLE 491 EMPTY CAPSULES MARKET: DEGREE OF COMPETITION
TABLE 492 EMPTY CAPSULES MARKET: REGION FOOTPRINT
TABLE 493 EMPTY CAPSULES MARKET: TYPE FOOTPRINT
TABLE 494 EMPTY CAPSULES MARKET: FUNCTIONALITY FOOTPRINT
TABLE 495 EMPTY CAPSULES MARKET: END-USER FOOTPRINT
TABLE 496 EMPTY CAPSULES MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS
TABLE 497 EMPTY CAPSULES MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SME PLAYERS, BY TYPE AND REGION
TABLE 498 EMPTY CAPSULES MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022-JULY 2025
TABLE 499 EMPTY CAPSULES MARKET: DEALS, JANUARY 2022-JULY 2025
TABLE 500 EMPTY CAPSULES MARKET: EXPANSIONS, JANUARY 2022-JULY 2025
TABLE 501 EMPTY CAPSULES MARKET: OTHER DEVELOPMENTS, JANUARY 2022-JULY 2025
TABLE 502 CAPSUGEL (LONZA): COMPANY OVERVIEW
TABLE 503 CAPSUGEL (LONZA): PRODUCTS OFFERED
TABLE 504 CAPSUGEL (LONZA): PRODUCT LAUNCHES, JANUARY 2022-JULY 2025
TABLE 505 CAPSUGEL (LONZA): OTHER DEVELOPMENTS, JANUARY 2022-JULY 2025
TABLE 506 ACG: COMPANY OVERVIEW
TABLE 507 ACG: PRODUCTS OFFERED
TABLE 508 ACG: EXPANSIONS, JANUARY 2022-JULY 2025
TABLE 509 ACG: OTHER DEVELOPMENTS, JANUARY 2022-JULY 2025
TABLE 510 QUALICAPS (ROQUETTE FRERES): COMPANY OVERVIEW
TABLE 511 QUALICAPS (ROQUETTE FRERES): PRODUCTS OFFERED
TABLE 512 QUALICAPS (ROQUETTE FRERES): DEALS, JANUARY 2022-JULY 2025
TABLE 513 QUALICAPS (ROQUETTE FRERES): EXPANSIONS, JANUARY 2022-JULY 2025
TABLE 514 SUHEUNG: COMPANY OVERVIEW
TABLE 515 SUHEUNG: PRODUCTS OFFERED
TABLE 516 SUHEUNG: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022-JULY 2025
TABLE 517 HEALTHCAPS INDIA: COMPANY OVERVIEW
TABLE 518 HEALTHCAPS INDIA: PRODUCTS OFFERED
TABLE 519 NECTAR LIFESCIENCES LTD.: COMPANY OVERVIEW
TABLE 520 NECTAR LIFESCIENCES LTD.: PRODUCTS OFFERED
TABLE 521 NECTAR LIFESCIENCES LTD.: DEALS, JANUARY 2022-JULY 2025
TABLE 522 SUNIL HEALTHCARE LIMITED: COMPANY OVERVIEW
TABLE 523 SUNIL HEALTHCARE LIMITED: PRODUCTS OFFERED
TABLE 524 NATURAL CAPSULES LIMITED: COMPANY OVERVIEW
TABLE 525 NATURAL CAPSULES LIMITED: PRODUCTS OFFERED
TABLE 526 NATURAL CAPSULES LIMITED: DEALS, JANUARY 2022-JULY 2025
TABLE 527 QINGDAO YIQING BIOTECHNOLOGY CO., LTD. (BAOTOU DONGBAO BIO-TECH CO., LTD.): COMPANY OVERVIEW
TABLE 528 QINGDAO YIQING BIOTECHNOLOGY CO., LTD. (BAOTOU DONGBAO BIO-TECH CO., LTD.): PRODUCTS OFFERED
TABLE 529 QINGDAO YIQING BIOTECHNOLOGY CO., LTD. (BAOTOU DONGBAO BIO-TECH CO., LTD.): PRODUCT LAUNCHES, JANUARY 2022-JULY 2025
TABLE 530 COMED CHEMICALS LIMITED: COMPANY OVERVIEW
TABLE 531 COMED CHEMICALS LIMITED: PRODUCTS OFFERED
TABLE 532 ANHUI HUANGSHAN CAPSULE CO., LTD.: COMPANY OVERVIEW
TABLE 533 ANHUI HUANGSHAN CAPSULE CO., LTD.: PRODUCTS OFFERED
TABLE 534 FORTCAPS (KUMAR ORGANIC PRODUCTS LIMITED): COMPANY OVERVIEW
TABLE 535 FORTCAPS (KUMAR ORGANIC PRODUCTS LIMITED): PRODUCTS OFFERED
TABLE 536 FORTCAPS (KUMAR ORGANIC PRODUCTS LIMITED): DEALS, JANUARY 2022-JULY 2025
TABLE 537 SHANDONG HEALSEE CAPSULE LTD. (SHANDONG HEAD GROUP CO., LTD.): COMPANY OVERVIEW
TABLE 538 SHANDONG HEALSEE CAPSULE LTD. (SHANDONG HEAD GROUP CO., LTD.): PRODUCTS OFFERED
TABLE 539 CAPSCANADA: COMPANY OVERVIEW
TABLE 540 CAPSCANADA: PRODUCTS OFFERED
TABLE 541 FARMACAPSULAS: COMPANY OVERVIEW
TABLE 542 FARMACAPSULAS: PRODUCTS OFFERED
TABLE 543 SHANXI GUANGSHENG MEDICINAL CAPSULE CO., LTD.: COMPANY OVERVIEW
TABLE 544 SHANXI GUANGSHENG MEDICINAL CAPSULE CO., LTD.: PRODUCTS OFFERED
TABLE 545 SHANXI GUANGSHENG MEDICINAL CAPSULE CO., LTD.: OTHER DEVELOPMENTS, JANUARY 2022-JULY 2025
TABLE 546 ERAWAT PHARMA LIMITED: COMPANY OVERVIEW
TABLE 547 ERAWAT PHARMA LIMITED: PRODUCTS OFFERED
TABLE 548 SAVIOURCAPS: COMPANY OVERVIEW
TABLE 549 SHANXI JC BIOLOGICAL TECHNOLOGY CO.: COMPANY OVERVIEW
TABLE 550 ROXLOR: COMPANY OVERVIEW
TABLE 551 MEDISCA INC.: COMPANY OVERVIEW
TABLE 552 ZHEJIANG YUEXI CAPSULE CO., LTD.: COMPANY OVERVIEW
TABLE 553 SHAOXING KANGKE CAPSULE CO., LTD.: COMPANY OVERVIEW
TABLE 554 ZHEJIANG HUILI CAPSULES CO., LTD.: COMPANY OVERVIEW
TABLE 555 SHAOXING ZHONGYA CAPSULE CO., LTD.: COMPANY OVERVIEW
TABLE 556 SHING LIH FANG ENTERPRISE CO., LTD.: COMPANY OVERVIEW
TABLE 557 LEFANCAPS: COMPANY OVERVIEW
TABLE 558 CHEMCAPS LIMITED: COMPANY OVERVIEW
TABLE 559 BIOCAPS ENTERPRISE: COMPANY OVERVIEW
TABLE 560 SNAIL PHARMA INDUSTRY: COMPANY OVERVIEW
TABLE 561 BRIGHT PHARMA CAPS: COMPANY OVERVIEW
TABLE 562 SHREE PHARMA CAPS: COMPANY OVERVIEW
TABLE 563 HEXIN CAPSULE CO., LTD.: COMPANY OVERVIEW
TABLE 564 WUHAN CARMA TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
TABLE 565 AIPAK PHARMA: COMPANY OVERVIEW

LIST OF FIGURES FIGURE 1 EMPTY CAPSULES MARKET SEGMENTATION & REGIONAL SCOPE

FIGURE 2 EMPTY CAPSULES MARKET: YEARS CONSIDERED
FIGURE 3 EMPTY CAPSULES MARKET: RESEARCH DESIGN
FIGURE 4 EMPTY CAPSULES MARKET: BREAKDOWN OF PRIMARIES (DEMAND- AND SUPPLY-SIDE PARTICIPANTS)
FIGURE 5 GLOBAL EMPTY CAPSULES MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2024
FIGURE 6 GLOBAL EMPTY CAPSULES MARKET SIZE ESTIMATION: COMPANY REVENUE ANALYSIS (BOTTOM-UP APPROACH), 2024
FIGURE 7 GLOBAL EMPTY CAPSULES MARKET SIZE ESTIMATION, BY VOLUME (2024)
FIGURE 8 GLOBAL EMPTY CAPSULES VOLUME-BASED MARKET SIZE ESTIMATION, BY VALUE (2024)
FIGURE 9 EMPTY CASPULES MARKET SIZE VALIDATION FROM PRIMARY EXPERTS
FIGURE 10 EMPTY CAPSULES SEGMENTAL MARKET ASSESSMENT (TOP-DOWN APPROACH)
FIGURE 11 GLOBAL EMPTY CAPSULES MARKET: CAGR PROJECTIONS (2025-2030)
FIGURE 12 EMPTY CAPSULES MARKET: DATA TRIANGULATION METHODOLOGY
FIGURE 13 EMPTY CAPSULES MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 14 GELATIN CAPSULES MARKET, BY RAW MATERIAL, 2025 VS. 2030 (USD MILLION)
FIGURE 15 NON-GELATIN CAPSULES MARKET, BY RAW MATERIAL, 2025 VS. 2030 (USD MILLION)
FIGURE 16 EMPTY CAPSULES MARKET, BY FUNCTIONALITY, 2025 VS. 2030 (USD MILLION)
FIGURE 17 EMPTY CAPSULES MARKET, BY SIZE, 2025 VS. 2030 (USD MILLION)
FIGURE 18 EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION, 2025 VS. 2030 (USD MILLION)
FIGURE 19 EMPTY CAPSULES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
FIGURE 20 REGIONAL SNAPSHOT OF EMPTY CAPSULES MARKET
FIGURE 21 INCREASING DEMAND FOR NUTRACEUTICALS AND PERSONALIZED SUPPLEMENTS TO PROPEL MARKET GROWTH
FIGURE 22 US AND GELATIN CAPSULES COMMANDED LARGER MARKET SHARES IN 2024
FIGURE 23 ANTIBIOTIC & ANTIBACTERIAL DRUGS SEGMENT ACCOUNTED FOR LARGEST SHARE IN EMPTY CAPSULES MARKET IN 2024
FIGURE 24 PHARMACEUTICAL INDUSTRY HELD LARGEST MARKET SHARE IN 2024
FIGURE 25 INDIA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
FIGURE 26 EMPTY CAPSULES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 27 TOTAL PRESCRIPTION DRUG SALES, 2016-2030 (USD BILLION)
FIGURE 28 NUMBER OF CLINICAL TRIALS REGISTERED, 2001-2024
FIGURE 29 EMPTY CAPSULES MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
FIGURE 30 AVERAGE SELLING PRICE TREND OF EMPTY CAPSULES, BY TYPE, 2022-2024 (USD)
FIGURE 31 AVERAGE SELLING PRICE TREND OF EMPTY CAPSULES, BY REGION, 2024 (USD)
FIGURE 32 EMPTY CAPSULES MARKET: VALUE CHAIN ANALYSIS
FIGURE 33 EMPTY CAPSULES MARKET: ECOSYSTEM ANALYSIS
FIGURE 34 EMPTY CAPSULES MARKET: PORTER'S FIVE FORCES ANALYSIS
FIGURE 35 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR EMPTY CAPSULES
FIGURE 36 KEY BUYING CRITERIA FOR EMPTY CAPSULES, BY END USER
FIGURE 37 TOTAL NUMBER OF PATENTS GRANTED, 2014-2024
FIGURE 38 TOP TEN PLAYERS/APPLICANTS WITH HIGHEST NUMBER OF PATENT APPLICATIONS, 2014-2024
FIGURE 39 EMPTY CAPSULES MARKET: VENTURE CAPITAL INVESTMENTS & NUMBER OF DEALS FOR SMALL MOLECULES, 2018-2024 (Q3)
FIGURE 40 AI USE CASES IN EMPTY CAPSULS MARKET
FIGURE 41 NORTH AMERICA: EMPTY CAPSULES MARKET SNAPSHOT
FIGURE 42 ORAL SOLID DOSAGE (OSD) PERCENTAGE OF NOVEL DRUG APPROVAL, 2022-2024
FIGURE 43 ASIA PACIFIC: EMPTY CAPSULES MARKET SNAPSHOT
FIGURE 44 REVENUE ANALYSIS OF KEY PLAYERS IN EMPTY CAPSULES MARKET, 2020-2024 (USD BILLION)
FIGURE 45 MARKET SHARE ANALYSIS OF KEY PLAYERS IN EMPTY CAPSULES MARKET (2024)
FIGURE 46 EMPTY CAPSULES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
FIGURE 47 EMPTY CAPSULES MARKET: COMPANY FOOTPRINT
FIGURE 48 EMPTY CAPSULES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
FIGURE 49 EV/EBITDA OF KEY VENDORS
FIGURE 50 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 51 EMPTY CAPSULES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 52 CAPSUGEL (LONZA): COMPANY SNAPSHOT
FIGURE 53 ACG: COMPANY SNAPSHOT
FIGURE 54 QUALICAPS (ROQUETTE FRERES): COMPANY SNAPSHOT
FIGURE 55 SUHEUNG: COMPANY SNAPSHOT
FIGURE 56 HEALTHCAPS INDIA: COMPANY SNAPSHOT
FIGURE 57 NECTAR LIFESCIENCES LTD.: COMPANY SNAPSHOT
FIGURE 58 SUNIL HEALTHCARE LIMITED: COMPANY SNAPSHOT
FIGURE 59 NATURAL CAPSULES LIMITED: COMPANY SNAPSHOT
FIGURE 60 QINGDAO YIQING BIOTECHNOLOGY CO., LTD. (BAOTOU DONGBAO BIO-TECH CO., LTD.): COMPANY SNAPSHOT
FIGURE 61 COMED CHEMICALS LIMITED: COMPANY SNAPSHOT
FIGURE 62 ANHUI HUANGSHAN CAPSULE CO., LTD.: COMPANY SNAPSHOT
FIGURE 63 FORTCAPS (KUMAR ORGANIC PRODUCTS LIMITED): COMPANY SNAPSHOT
FIGURE 64 SHANDONG HEALSEE CAPSULE LTD. (SHANDONG HEAD GROUP CO., LTD.): COMPANY SNAPSHOT

Empty Capsules Market by Type, Raw Material, Functionality, Application, Size, End User - Global Forecast to 2030

Description

Table of Contents

List of Tables

The primary interviews conducted for this report can be categorized as follows:

List of Key Companies Profiled in the Report:

Research Coverage:

Key Benefits of Buying the Report:

The report provides insights on the following pointers:

TABLE OF CONTENTS

1 INTRODUCTION

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW

6 EMPTY CAPSULES MARKET, BY TYPE

7 EMPTY CAPSULES MARKET, BY RAW MATERIAL

8 EMPTY CAPSULES MARKET, BY FUNCTIONALITY

9 EMPTY CAPULES MARKET, BY SIZE

10 EMPTY CAPSULES MARKET, BY THERAPEUTIC APPLICATION

11 EMPTY CAPSULES MARKET, BY END USER

12 EMPTY CAPSULES MARKET, BY REGION

13 COMPETITIVE LANDSCAPE

14 COMPANY PROFILES

15 APPENDIX

List of Tables

List of Figures